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In recent years, the use of a number of drugs, including antibiotics and antimalarials,
which have undesirable tastes, has been increasing. Although antimalarials are widely
administered parenterally, oral administration is more convenient and acceptable to pa-
tients. Oral administration of antimalarials, especially to children, is often hampered by
their unpleasant bitter taste. This leads to non-compliance and hinders therapeutic ma-
nagement.
Artemether (ARM), a drug used for treatment of malaria, has an extremely unpleas-
ant bitter taste. The exact mechanism of bitterness is unknown. However, it has been re-
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The objective of the present investigation was to reduce
the bitterness of artemether (ARM). Microparticles were
prepared by the coacervation method using Eudragit E
100 (EE) as polymer and sodium hydroxide solution as
nonsolvent for the polymer. A 32 full factorial design was
used for optimization wherein the amount of drug (A) and
polymer (B) were selected as independent variables and
the bitterness score, particle size and drug release at pH,
1.2 and 6.8 were selected as dependent variables. Opti-
mization was carried out using the desirability function.
The optimized microparticles batch was characterized by
FTIR and DSC. Multiple linear regression analysis revea-
led that reduced bitterness of ARM can be obtained by
controlling the drug release of microparticles at pH 6.8
and increasing the amount of EE. The increase in the amo-
unt of polymer leads to reduction in drug release from
microparticles at pH > 5 due to its insolubility and thus
reduces bitterness. However, the increase in the amount
of polymer results in improved dissolution, suggesting im-
proved availability of ARM in stomach. Optimized mi-
croparticles prepared using 0.04 g of ARM and 15 mL of
1% (m/V) solution of EE showed complete bitter taste
masking with improved drug release at pH 1.2.
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ported that drugs like ARM bind to the membrane receptor, present on the apical taste
cells and thus produce bitterness (1, 2). As this is likely to give rise to non-compliance
when administered orally, it would be a considerable advantage to mask the bitterness
of ARM and incorporate it in a palatable formulation (3).
Various masking techniques such as the addition of sweeteners and flavors, coating
with water-insoluble polymers, adsorption to ion-exchange resin, microencapsulation with
various polymers, complexing with cyclodextrins, melt granulation and chemical modi-
fications such as the use of insoluble prodrugs have been tried (4). Among the various
techniques, microencapsulation has often proved to be most successful in reducing the
bitterness of bitter active pharmaceutical ingredients because it is simple, economic and
advantageous.
Eudragit E 100 (EE) is a cationic copolymer based on dimethyl aminoethyl metha-
crylate and neutral methacrylic esters soluble up to pH 5 (5). In addition, the polymer
retards the drug release above pH 5 due to its insolubility. The pH inside the oral cavity
has been reported to be about 6.8 (6). Thus, EE retards drug release at pH 6.8 and acts as
a physical barrier between the drug and taste cells. This results in taste masking of bitter
drugs.
Various methods such as coating, dispersion coating, spray drying and emulsion sol-
vent diffusion have been reported (7, 8). In the present study, microparticles were pre-
pared using the coacervation phase separation method. Sodium hydroxide was used as
nonsolvent for the polymer.
The objective of the present investigation was to completely disguise the bitter taste
of ARM by encapsulation in microparticles and to develop a palatable formulation. A 32
full factorial design was used for optimization of microparticles wherein the drug con-
centration (A) and polymer concentration (B) were selected as independent variables while




Eudragit E 100 (Batch no. G041131159) was a gift from Degussa India Pvt. Ltd. (In-
dia). Methanol was purchased from Qualigens Fine Chemicals (India) and was used as
received. Sodium hydroxide, hydrochloric acid, potassium chloride, potassium dihydro-
gen phosphate, and acetic acid were purchased from S. D. Fine-Chem Ltd. (India) and
were used as received.
Preparation of microparticles
Microparticles were prepared by the coacervation phase separation method. A con-
centrated solution of EE (1%, m/V) was prepared in 1%, V/V acetic acid. The required
quantity of ARM (0.04 g in 15 mL of 1%, m/V, EE solution) was mixed for 5 min. 10 mL
of 10%, m/V sodium hydroxide solution was introduced into a 10-mL glass syringe with
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a flat-cut hypodermic needle and added dropwise into the EE solution. Different con-
centrations of ARM and EE were used as mentioned in Table I. The resulting microparti-
cles were allowed to harden for 60 min under gentle stirring (Remi Equipments Pvt. Ltd.,
India) with a small magnetic bar, decanted on a Büchner funnel, rinsed with deionized
doubly-distilled water, and dried to a constant mass in a hot air oven (Shree Kailash In-
dustries, India) at 70 °C for 24 hours, and then stored in the desiccator until use.
Experimental design
A 32 full factorial design was employed to systematically study the joint influence
of independent variables, amount of drug (A), and polymer (B), on the dependent vari-
ables such as particle size, drug release at pH, 1.2 and 6.8 along with bitterness score. In
this design, 2 factors were evaluated, each at 3 levels, and experimental runs were per-
formed in all 9 possible combinations. The experimental runs along with their measured
responses (dependent variables) are reported in Table II.
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Table I. Process variables and their levels for the 32 full factorial design
Coded values
Actual values




a mL of 1% (m/V) EE solution.








scoreA B pH 1.2 (%)a,b pH 6.8 (%)a,c
ARM1 –1 –1 83.6 ± 1.3 44.08 ± 4.29 62.6 ± 1.1 4.4 ± 0.8 1
ARM2 0 –1 74.5 ± 1.7 45.17 ± 3.84 72.6 ± 1.0 4.2 ± 0.8 2
ARM3 1 –1 79.5 ± 1.5 45.31 ± 3.16 85.7 ± 1.0 5.4 ± 0.6 3
ARM4 –1 0 82.5 ± 1.2 142.58 ± 4.37 79.3 ± 1.3 5.7 ± 0.7 0
ARM5 0 0 78.9 ± 1.2 92.46 ± 3.52 84.3 ± 0.9 5.6 ± 0.9 0
ARM6 1 0 84.3 ± 1.4 64.49 ± 3.74 89.3 ± 1.2 6.5 ± 0.6 1
ARM7 –1 1 77.9 ± 1.2 241.84 ± 3.93 93.4 ± 1.2 3.8 ± 0.8 0
ARM8 0 1 82.8 ± 0.8 120.72 ± 3.24 90.4 ± 1.3 3.7 ± 0.8 0
ARM9 1 1 83.4 ± 1.3 54.36 ± 4.63 87.3 ± 1.0 4.5 ± 0.9 0
a Mean ± SD, n = 3.
b,c Percent drug released in 15 and 5 min, respectively.
A statistical model incorporating interactive and polynomial terms was used to eva-
luate the response (9):
Y b b A b B b A b B b AB= + + + + +0 1 2 11 22 122 2 (1)
where, Y is the dependent variable, b0 is the arithmetic mean response of the nine runs
while b1 and b2 are the estimated coefficients for the factors A and B. The main effects
(A and B) represent the average result of changing one factor at a time from its low to
high value. The interaction terms (AB) show how the response changes when 2 factors
are simultaneously changed. The polynomial terms (A2 and B2) are included to investi-
gate nonlinearity.
Further, the model was evaluated for the best fit using various statistical parameters
such as PRESS (predicted residual error sum of squares), Adj-R2, Pred-R2 and Adeq Pre-
cision. PRESS (predicted residual error sum of squares) indicates how well the model
fits the data. Coefficients for the model were calculated without the first point. This new
model was then used to estimate the first point and calculate the residual for point one.
This was done for each data point and the squared residuals were summed.
Adj-R2 measures the variation around the mean explained by the model, adjusted
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Adequate precision (Adeq Precision) is a signal to noise ratio. It compares the range







where p is the number of model parameters including intercept (b0), d is the residual
mean square (MS) from the ANOVA table and n is the number of experiments (10).
Incorporation efficiency
Microparticles containing 10 mg of the drug were weighed accurately and dissolved
in methanol. Drug concentration was determined by UV spectrophotometry (UV visible
spectrophotometer 1700, Shimadzu, Japan) at 256 nm. A calibration curve was used, ba-
sed on standard solutions in methanol.
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Particle size analysis
The average particle diameter and size distribution of microparticles were determi-
ned using Malvern (Mastersizer 2000, Malvern Instruments, UK). Approximately 10 mg
of microparticles were dispersed in 2–3 mL of filtered and degassed phosphate buffer,
pH 6.8, containing 0.1% Tween 80 for one minute using an ultrasonic bath. An aliquot of
the microparticle suspension was then added into the small volume recirculation unit
and circulated at 3500 rpm. Each sample was measured in triplicate. Particle size was ex-
pressed as the weighted mean of volume distribution.
In vitro drug release
The in vitro release profile of plain ARM and optimized microparticles was deter-
mined according to the paddle method, described in the United States Pharmacopoeia XXIV
(11). The in vitro drug release study was carried out in phosphate buffer, pH 6.8, because
the pH of the saliva is in the range from 6.8–7.2. Further, the in vitro drug release study
was performed in hydrochloric acid buffer, pH 1.2, to demonstrate the availability of ARM
in gastric pH. Microparticles containing an equivalent of 50 mg of ARM were suspended
in 900 mL of buffer solution, and a 3 mL sample was withdrawn at 1, 5, 10, 15, 30 and 60
min and analyzed using a UV spectrophotometer at 256 nm. Each sample was replaced
with fresh buffer solution of the same temperature.
Gustatory sensation test
Gustatory sensation test was carried out according to the method of Shah et al. (10).
Twenty volunteers participated in the sensory test. One gram of microparticles was dis-
persed in 100 mL of water for 15 s. ARM was used as a control. Immediately after prepa-
ration, each volunteer held about 1 mL of the dispersion in the mouth for 30 s. After ex-
pectoration, the bitterness level was recorded. A numerical scale was used with the foll-
owing values: 0 – tasteless, 0.5 – very slightly bitter, 1 – slightly bitter, 1.5 – slightly to
moderately bitter, 2 – moderately bitter, 2.5 – moderately to strongly bitter, 3 – strongly
bitter, 3+ – very strongly bitter. The threshold of bitterness of microparticles was deter-
mined as the point at which most volunteers described the taste as bitter or slightly biter.
Optimization of responses using desirability
The multiple response method makes use of an objective function called the desir-
ability function. It reflects the desirable ranges for each response (di). Each response is
associated with its own partial desirability function. If the value of the response is opti-
mal, its desirability equals 1, and if it is totally unacceptable, its value is zero. Thus, the
desirability for each response can be calculated at a given point in the experimental do-
main. The optimum is the point with the highest value of desirability (12).
The percent drug release at pH 1.2 was aimed at maximum since higher value was
desired. Higher percent drug release at pH 1.2 leads to greater availability of ARM in the
stomach. Moreover, microparticles showed complete release within a few minutes. Hence,
the percent drug release at 15 min (t15) was selected. The Ymin and Ymax values of per-
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cent drug release at pH 1.2 in 15 min (t15) were 62.57 and 93.39, respectively. The desir-















where di is individual desirability, Yi is the experimental result and s is used to change
the shape of the desirability goal by the weight field.
To avoid grittiness of microparticles after ingestion in oral cavity, minimal particle
size was desired. The observed Ymin and Ymax particle size values were 44.08 and 241.84,
respectively. The problem of bitter taste of the drug is generally encountered due to dis-
solution of the active component in oral cavity. Microparticles remain in oral cavity for
maximally 5 min. To avoid this, minimal percent drug release at 5 min was desired. The
Ymin and Ymax values of percent drug release at pH 6.8 in 5 min (t5) were 3.7 and 6.47,
respectively. Similarly, the lowest bitterness score value was desired for complete taste
masking. Though the observed Ymax value of the bitterness score was 3, 0.5 was sele-
cted because very slight bitterness was desired. The Ymax and Ymin values of bitterness
score were 0.5 and 0, respectively. Thus, the desirability function of the particle size, drug















where di is individual desirability, Yi is the experimental result and s is used to change
the shape of the desirability goal by the weight field. In all the experiments performed,
all the experimental values were acceptable; however, the values far from the target were
penalized by choosing 0 < s < 1 (1 in this case) in Eqs. 7, 8 and 9.














if Ymin  Yi  Ymax (8)
di = 0 if Yi > Ymax (9)
The overall desirability was calculated from the individual values by using the fol-
lowing equation:
D d d d d di
i












where D is overall desirability and d1, d2, d3, d4 are individual desirability values of
measured responses.
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Fourier transform infra-red spectroscopy (FTIR)
FTIR transmission spectra of pure ARM, EE, blank microparticles and optimized mi-
croparticles were obtained using a Fourier Transform Infrared Spectrophotometer (FTIR-
-8300, Shimadzu, Japan). A total of 2% (m/m) of the sample, with respect to the potas-
sium bromide (S. D. Fine Chem Ltd., India), was mixed with dry KBr.
Differential scanning calorimetry (DSC)
A differential scanning calorimetry study of pure ARM, EE, blank microparticles and
optimized microparticles was performed using a Mettler Toledo, DSC 822e DSC (Mettler
Toledo, Switzerland). All the samples were accurately weighed (5–8 mg), sealed in alu-
minium pans and heated at a scanning rate of 5 °C min–1. Nitrogen was used as the purge
gas with the flow rate set at 40 mL min–1. Aluminum pans and lids were used for all
samples. An empty aluminum pan was used as a reference.
RESULTS AND DISCUSSION
Experimental design
Preliminary investigations of process parameters revealed that the factors, amount
of drug (A) and polymer (B), highly influenced the bitterness in human volunteers, par-
ticle size, drug release at pH 1.2 and 6.8. Hence, A and B were used for further systema-
tic studies. The dependent and independent variables were related using mathematical
relationships obtained with the statistical package DOE v6.0.5 (Stat-Ease, Inc.). The fit-
ted polynomial equations (full and reduced model) relating the response to the trans-
formed factors are shown in Table III. Polynomial equations can be used to draw conclu-
sions after considering the magnitude of the coefficient and the mathematical sign it carries,
i.e., positive or negative. F-value compares the variance with the residual (error) vari-
ance. The terms having Prob > F value over 0.05 were omitted in the reduced model (13, 14).
Multiple linear regression analysis (Table III) revealed that A2 and B2 terms were in-
significant for particle size while the A2 term was insignificant for bitterness score and
dissolution at pH 1.2. The term AB was insignificant for drug release at pH 6.8. The sur-
face plots are shown in Fig. 1.
Table IV shows the results of the analysis of variance (ANOVA), which was perfor-
med to identify insignificant factors (15). High values of the square root correlation coef-
ficient (R2) for all dependent variables indicate a good fit.
PRESS values for all formulations showed a good fit of the model. Adj-R2 and Pred-
-R2 values were in reasonable agreement, signifying good model fit. Further models, full
model (FM) and reduced model (RM), showed the Adeq precision value greater than 4, in-
dicating adequate model discrimination.
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Incorporation efficiency is an important factor in evaluation of the quality of micro-
particles. Incorporation efficiency varied for all batches as shown in Table II. The high
ARM content in the microparticles was believed to be due to poor solubility of ARM in
EE solution. Incorporation efficacy improves with an increase in polymer (16). This sug-
gests that the present method is suitable for the preparation of microparticles of a poorly
water-soluble drug, such as ARM.
Particle size
For particle size, the amount of ARM is negative while the amount of EE is positive.
This indicates that on increasing the amount of EE, the particle size increases. It was ob-
served that polymer viscosity influenced the particle size (16). Increasing the amount of
EE led to an increase in its viscosity and consequently a decrease in the frequency of dis-
sociation or separation of particles with the addition of sodium hydroxide. This resulted
in an increase in the overall size of microparticles.
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Fig. 1. Surface plots showing the effect of the amount of drug and polymer on particle size, drug re-
lease at pH 1.2 and 6.8, along with bitterness score.
In vitro drug release
In the case of in vitro drug release at pH 1.2, the amounts of ARM and EE are posi-
tive. This indicates the additive effect of the amount of ARM and EE. This suggests that
ARM release would be improved at acidic pH, resulting in improved availability of ARM
in the stomach. ARM release from microparticles was completed within a few minute,
followed by a plateau. This may be due to the high porosity of microparticles, the hydro-
philic nature of EE, and improved wettability provided by the dissolved EE (17).
In the case of in vitro drug release at pH 6.8, the amount of ARM is positive while
the amount of EE is negative. This indicates that on increasing the amount of EE, drug
release from microparticles decreases. As the amount of EE increased, a thicker film was
formed around the ARM particles, which retarded ARM release because of being insolu-
ble at salivary pH (10). EE is expected to behave as an insoluble and inert material at pH
6.8 and to show decreased drug release. This is due to the decrease in drug diffusion
and/or membrane infiltration (17). Fig. 2 shows the dissolution profile of ARM and op-
timized microparticles at pH 1.2 and 6.8.
Gustatory sensation test
In the case of bitterness score, the amount of ARM is positive while the amount of
EE is negative. This indicates that on increasing the amount of EE, the bitterness score of
microparticles decreases. This finding is in agreement with the in vitro drug release study
carried out at pH 6.8, because the pH of the saliva is 6.8 (4). It has been reported that bit-
ter drugs like ARM seem to bind G-protein coupled receptors, present on the apical taste
cell membrane, and produce bitterness (1). EE is expected to behave as insoluble at pH
6.8 and to show decreased drug release in microparticles. Thus, EE forms a physical bar-
rier between ARM and G-protein coupled receptors present on the apical taste cell mem-
brane and reduces the bitterness score of ARM in microparticles.
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ARM at pH 6.8
ARM at pH 1.2
Microparticles at pH 1.2
Microparticles at pH 6.8
Fig. 2. Dissolution profile
of ARM and optimized
microparticles at pH
1.2 and 6.8 (mean ± SD,
n = 3).
Optimization using desirability function
A process can only be authenticated when the optimum level of its variables (affect-
ing the process) for a product of good quality characteristics is recognized. Desirability
function is an excellent tool for identifying the optimum levels of variables. In this pro-
cedure, all the measured responses for independent variables that are supposed to affect
the quality of the product are taken into consideration. Particle size, drug release at pH
6.8 and bitterness score have to be minimized while drug release at pH 1.2 has to be
maximized in order to pour desired characteristics into the product. Using the desirabi-
lity function, all the measured responses were combined to get one overall response, i.e.,
the overall desirability. The overall desirability response was calculated from the indi-
vidual desirability of each of the responses using DOE v6.0.5. The optimized batch was
identified with a desirability value of 0.88. Table V lists the optimized values for inde-
pendent variables and their responses.
Fourier transform infra-red spectroscopy
The FTIR spectrum of ARM, EE, blank microparticles and optimized microparticles
are shown in Fig. 3. The characteristic peaks of ARM at 2873 cm–1 are assigned to C-H
389
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Fig. 3. FTIR spectra of a)
ARM, b) EE, c) blank mi-
croparticles and d) opti-
mized microparticles.










A (g) B (mL)d pH 1.2 (%)a,b pH 6.8 (%)a,c
0.04 15 82.9 ± 1.3 85.9 ± 1.5 89.4 ± 1.3 4.2 ± 0.7 0 0.88
a Mean ± SD, n = 3.
b,c Percent drug released in 15 and 5 min respectively.
d mL of 1% (m/V) EE solution.
stretching vibration in CH3, CH2. In addition, the absorption peak at 2844 cm–1 can be
assigned to C-H stretching vibration in C-O-CH3. The peak at 1137 cm–1 can be assigned
to C-O stretching vibration in C-O-C. The peaks at 2953 and 2916 cm–1 are assigned to
C-H stretching in -CH3. The EE spectrum is dominated by the carbonyl (C=O) stretching
vibration at 1735 cm–1 and the ester C-O stretching vibrations at 1148 and 1188 cm–1. In
addition, C-H vibrations can be discerned at 1389, 1450–1490 and 2962 cm–1. The absorp-
tions at 2772 and 2822 cm–1 can be assigned to the dimethylamino groups. The spectrum
of microparticles corresponds to the superimposition of ARM and EE with no significant
shift of major peaks. This confirms the presence of ARM in microparticles.
Differential scanning calorimety
Fig. 4 shows the DSC curve of ARM, EE blank microparticles and microparticles.
Pure ARM shows an endothermic peak at 87.94 °C, followed by an exothermic peak at
180.28 °C. The endothermic peak corresponding to the melting peak of ARM was broad-
ened and shifted towards lower temperature, with reduced intensity in microparticles.
This could be attributed to higher polymer concentration and uniform distribution of
the drug in the polymer crust, resulting in complete miscibility of molten drug in the
polymer. The FTIR and DSC studies indicated uniform dispersion of ARM, at the molec-
ular level, in EE microparticles.
CONCLUSIONS
The study has conclusively demonstrated complete taste masking of ARM in micro-
particles using EE as polymer. The present work suggests that the amount of drug (A)
and polymer (B) has its own significant complementary role in enhancement of the pro-
cess rather than having an exclusive effect. Application of experimental design along with
desirability function can be an ideal tool to optimize independent variables like the amount
390
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Fig. 4. DSC curve of a)
ARM, b) EE, c) blank mi-
croparticles and d) opti-
mized microparticles.
of ARM and EE, which have a significant effect on microparticles’ desired properties.
The bitterness of ARM was reduced successfully in EE microparticles.
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S A @ E T A K
Dizajniranje i optimizacija mikrokapsula artemetera za maskiranje gorkog okusa
PUNIT P. SHAH, RAJASHREE C. MASHRU, YOGESH M. RANE i ATUL C. BADHAN
Cilja ovog rada je bio maskirati gorki okus artemetera (ARM) mikrokapsuliranjem.
Mikro~estice su pripravljene metodom koacervacije pomo}u Eudragita E 100 (EE) kao
polimerne komponente i natrijevog hidroksida u kojem se polimer ne otapa. 32 fakto-
rijalni dizajn upotrebljen je za optimizaciju. Koli~ine ljekovite tvari (A) i polimera (B) iza-
brane su kao nezavisne varijable, a intenzitet gorkog okusa, veli~ina ~estica i osloba|a-
nje ljekovite tvari pri pH 1,2 i 6,8 izabrane su kao zavisne varijable. Optimizirane mikro-
~estice karakterizirane su pomo}u FTIR i DSC. Multipla linearna regresijska analiza
otkrila je da se smanjenje gor~ine artemetera mo`e posti}i kontroliranjem osloba|anja lje-
kovite tvari pri pH 6,8 i pove}anjem koli~ine EE. Pove}anje koli~ine polimera smanjuje
osloba|anje ljekovite tvari pri pH > 5 pa se smanjuje i gor~ina. Me|utim, pove}anje koli-
~ine polimera pove}ava topljivost ljekovite tvari, a time potencijalno i njenu raspolo`lji-
vost u `elucu. U optimiziranim mikro~esticama pripravljenim pomo}u 0,04 g ARM i 15
mL 1% m/V otopine EE potpuno se maskirao gorki okus, a osloba|anje ljekovite tvari pri
pH 1,2 bilo je pobolj{ano.
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